We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.91B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
-3.91%
1 Year Est. Return
+24.21%
3 Year Est. Return
+168.27%
5 Year Est. Return
+91.75%
10 Year Est. Return
+1,020.11%
AUM
$2.15B
AUM Growth
-$724M
Cap. Flow
-$587M
Cap. Flow %
-27.33%
Top 10 Hldgs %
99.84%
Holding
13
New
–
Increased
1
Reduced
4
Closed
1
Avg Time Held
13.5 quarters
Top 10 Avg Time Held
8.7 quarters
Top 20 Avg Time Held
10.6 quarters

Top Buys

Rank Stock Value
1
ALKT icon
Alkami Technology
ALKT
+$61.6M

Top Sells

Rank Stock Value
1
ALHC icon
Alignment Healthcare
ALHC
+$260M
2
RVMD icon
Revolution Medicines
RVMD
+$213M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$122M
4
XP icon
XP
XP
+$41.2M
5
NRIX icon
Nurix Therapeutics
NRIX
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 58.87%
2 Healthcare 19.23%
3 Financials 18.23%
4 Consumer Staples 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DLO icon
1
dLocal
DLO
$4.47B
$605M 28.17%
46,656,695
– –
2021 Q2
19 quarters
CHYM icon
2
Chime Financial
CHYM
$11.5B
$398M 18.53%
21,259,683
– –
2025 Q2
3 quarters
XP icon
3
XP
XP
$16.5B
$392M 18.23%
20,566,133
-2,133,000
-9% -$41.2M
2019 Q4
25 quarters
ALKT icon
4
Alkami Technology
ALKT
$1.51B
$240M 11.19%
15,337,495
+3,346,015
+28% +$61.6M
2021 Q2
19 quarters
PHVS icon
5
Pharvaris
PHVS
$2.17B
$227M 10.56%
8,031,252
– –
2021 Q1
20 quarters
EWCZ icon
6
DELISTED
European Wax Center
EWCZ
$75.8M 3.53%
13,110,492
– –
2021 Q3
18 quarters
RVMD icon
7
Revolution Medicines
RVMD
$41.6B
$68.8M 3.2%
707,791
-2,105,137
-75% -$213M
2025 Q3
2 quarters
NRIX icon
8
Nurix Therapeutics
NRIX
$2.3B
$63.6M 2.96%
4,101,865
-795,294
-16% -$13.2M
2025 Q4
1 quarter
CNTA
9
DELISTED
Centessa Pharmaceuticals
CNTA
$53.8M 2.5%
1,354,830
-4,762,885
-78% -$122M
2021 Q2
19 quarters
RSKD icon
10
Riskified
RSKD
$1.13B
$20.9M 0.97%
5,324,998
– –
2021 Q3
18 quarters
GROV icon
11
Grove Collaborative
GROV
$43.1M
$3.17M 0.15%
2,474,859
– –
2022 Q2
15 quarters
BULL icon
12
Webull Corp
BULL
$3.4B
$244K 0.01%
50,816
– –
2025 Q2
3 quarters
ALHC icon
13
Alignment Healthcare
ALHC
$1.68B
– –
-13,167,733
Closed -$260M –

Similar funds

LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $2.91B AUM 27.09% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.91B AUM 24.25% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
7WCP
71 West Capital Partners Boston, Massachusetts $2.89B AUM
JC
JB Capital Wethersfield, Connecticut $2.89B AUM 29.25% 1-Year Est. Return

General Atlantic's Q1 2026 Portfolio in Review

As of Q1 2026, General Atlantic held 13 positions worth $2.15B, down 25% from $2.87B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

General Atlantic withdrew a net $587M in Q1 2026, closing 1 position and reducing 4 holdings. Its most notable exit was Alignment Healthcare, an estimated $260M position sold in full.

By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 52% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Atlantic added an estimated $61.6M to Alkami Technology.

  • General Atlantic added most to Alkami Technology in Q1 2026, an estimated $61.6M increase.
  • General Atlantic's biggest Q1 2026 reduction was Revolution Medicines, cutting an estimated $213M.
  • General Atlantic fully exited Alignment Healthcare in Q1 2026, selling an estimated $260M.
  • General Atlantic's ten largest holdings make up 100% of its $2.15B portfolio in Q1 2026.
  • General Atlantic opened 0 new positions and closed 1 in Q1 2026.
  • General Atlantic's portfolio value fell 25% quarter-over-quarter to $2.15B.

Based on General Atlantic's 13F filing for Q1 2026, filed 15 May 2026.